ホルモン療法の世界市場レポート 2025年

ホルモン療法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8％で284億6,000万米ドルに成長します。予測期間の成長は、個別化医療へのアプローチ、高齢化のダイナミクス、女性の健康へのアプローチへのシフト、ウェルネスと長寿へのフォーカス、規制の適応に起因すると考えられます。予測期間の主な動向には、規制の変更とガイドライン、ライフスタイルとストレスの変化、研究開発、意識と教育の拡大が含まれます。

ホルモン療法市場の成長には、ホルモンバランスの乱れの急増が大きく寄与しています。ホルモンバランスの乱れは、体内のホルモン産生量が過剰または不足することで発生し、甲状腺機能低下症、性腺機能低下症、成長ホルモン欠乏症などの様々な疾患を引き起こします。これらの障害に対処するために、エストロゲン補充、テストステロン補充、インスリン療法などのホルモン療法が採用されています。ロンドン・メディカル・ラボラトリーによる2022年の報告書では、2年前と比較して著しいホルモンバランスの乱れが19％増加すると予想されています。その結果、ホルモンバランスの乱れの有病率の上昇がホルモン療法市場を促進すると予想されます。

高齢者の増加は、今後数年間のホルモン療法市場の拡大を促進すると予測されています。高齢者とは、人生の後期段階にある人のことで、高齢者人口や高齢者に関連することが多いです。高齢者向けのホルモン療法は、特に加齢に関連した健康問題について、ホルモンバランスの乱れを整え、加齢に関連した特定の状態に対処することを目的としています。例えば、2024年7月、英国の政府機関である英国議会は、英国の人口が2026年までに7,000万人に達すると予測しました。さらに、高齢化も進んでおり、2022年には65歳以上の高齢者が19％を占め、2072年には27％まで増加すると予想されています。このように、高齢者の増加がホルモン療法市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ホルモン療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のホルモン療法市場：成長率分析
• 世界のホルモン療法市場の実績：規模と成長, 2019-2024
• 世界のホルモン療法市場の予測：規模と成長, 2024-2029, 2034F
• 世界ホルモン療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のホルモン療法市場セラピーによって、実績と予測, 2019-2024, 2024-2029F, 2034F
• エストロゲンホルモン補充療法
• 成長ホルモン補充療法
• 甲状腺ホルモン補充療法
• テストステロン補充
• 世界のホルモン療法市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界のホルモン療法市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 閉経
• 甲状腺機能低下症
• 成長ホルモン欠乏症
• その他の適応症
• 世界のホルモン療法市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局および店舗
• オンライン薬局
• 世界のホルモン療法市場エストロゲンホルモン補充療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全身エストロゲン療法
• 局所エストロゲン療法
• エストロゲン・プロゲスチン併用療法
• 世界のホルモン療法市場成長ホルモン補充療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換え成長ホルモン
• 合成成長ホルモン
• 世界のホルモン療法市場、甲状腺ホルモン補充療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• レボチロキシン
• リオチロニン
• 天然乾燥甲状腺
• 世界のホルモン療法市場、テストステロン補充療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射用テストステロン
• 経皮テストステロン
• 経口テストステロン
• ペレット

第7章 地域別・国別分析

• 世界のホルモン療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のホルモン療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ホルモン療法市場：競合情勢
• ホルモン療法市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Mylan NV
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Abbvie Inc.
• Teva Pharmaceutical Industries Ltd.
• Perrigo Company Plc.
• Cipla Inc.
• Lupin Limited
• Sun Pharmaceuticals Industries Ltd.
• Hikma Pharmaceuticals PLC.
• Johnsons & Johnsons Services Inc.
• Boehringer Ingelheim International GmbH
• Sanofi S.A.
• AstraZeneca plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ホルモン療法市場2029：新たな機会を提供する国
• ホルモン療法市場2029：新たな機会を提供するセグメント
• ホルモン療法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hormone therapy is a form of treatment aimed at modifying, suppressing, or increasing specific hormones within the body. This therapeutic approach is employed to address hormonal imbalances, such as hypothyroidism and other related conditions.

Key categories of hormone therapy include estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Estrogen hormone replacement therapy involves the administration of estrogen to elevate the body's estrogen levels. This treatment is delivered through various routes, including oral and parenteral methods. It finds application in conditions such as menopause, hypothyroidism, and growth hormone deficiency. Distribution channels for hormone therapy encompass hospital pharmacies, retail pharmacies, and online pharmacies.

The hormone therapy market research report is one of a series of new reports from The Business Research Company that provides hormone therapy market statistics, including hormone therapy industry global market size, regional shares, competitors with a hormone therapy market share, detailed hormone therapy market segments, market trends and opportunities, and any further data you may need to thrive in the hormone therapy industry. This hormone therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormone therapy market size has grown strongly in recent years. It will grow from $19.7 billion in 2024 to $21.1 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to medical advancements, women's health revolution, increased awareness and education, clinical research and development, shifting healthcare practices.

The hormone therapy market size is expected to see strong growth in the next few years. It will grow to $28.46 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine approach, aging population dynamics, shift in women's health approaches, focus on wellness and longevity, regulatory adaptations. Major trends in the forecast period include regulatory changes and guidelines, changing lifestyles and stress, research and development, expanding awareness and education.

The growth of the hormone therapy market is significantly fueled by a surge in the incidences of hormone imbalance disorders. Hormone imbalance occurs when the body produces an excess or insufficient amount of a hormone, leading to various disorders such as hypothyroidism, hypogonadism, and growth hormone deficiency. Hormone therapies, including estrogen replacement, testosterone replacement, and insulin therapy, are employed to address these disorders. A 2022 report by London Medical Laboratory revealed an anticipated 19% increase in significant hormone imbalances compared to two years prior. Consequently, the rising prevalence of hormone imbalance disorders is expected to propel the hormone therapy market.

The growing number of elderly individuals is anticipated to drive the expansion of the hormone therapy market in the coming years. Elderly individuals are those in the later stages of life, often associated with the older population or seniors. Hormone therapy for the elderly, especially regarding age-related health issues, aims to rectify hormonal imbalances and address specific conditions linked to aging. For example, in July 2024, the UK Parliament, a UK-based governmental organization, projected that the population of the UK would reach 70 million by 2026. Furthermore, the population is aging, with 19% of individuals aged 65 or older in 2022, a figure expected to increase to 27% by 2072. Thus, the rising number of elderly individuals is propelling the growth of the hormone therapy market.

Leading companies in the hormone therapy market are focusing on innovative solutions, such as direct-to-consumer telehealth models, to improve accessibility and convenience for patients. The direct-to-consumer telehealth model for hormone therapy is a healthcare system that enables patients to access hormone therapy remotely, without needing traditional in-person consultations. For example, in September 2023, LifeMD, a US-based telehealth company, partnered with ASCEND Therapeutics, a US-based pharmaceutical company, to launch an integrated direct-to-consumer telehealth model for hormone therapy, focusing on EstroGel (estradiol gel) to treat menopausal symptoms. This collaboration allows patients to utilize LifeMD's telehealth services directly through the EstroGel website, where they can consult with licensed healthcare providers who can prescribe the medication and arrange home delivery. By simplifying access and addressing barriers such as long wait times, this initiative aims to improve health outcomes for women seeking menopause treatment.

Companies in the hormone therapy market are adopting strategic partnerships to commercialize hormone therapy in North Africa and the Middle East. Strategic partnerships involve companies leveraging their strengths and resources to achieve shared goals. For instance, in October 2023, Cosmo Pharmaceuticals N.V., an Ireland-based pharmaceutical manufacturer of hormonal drugs, announced a strategic agreement with Hikma Pharmaceuticals PLC. Under this deal, Hikma will receive the exclusive rights to register and market Winlevi in 17 countries across the Middle East and North Africa (MENA) region from Cassiopea, a subsidiary of Cosmo. In return, Cassiopea will receive an initial payment of USD 750,000, along with future regulatory and commercial milestone payments. Cassiopea will remain the sole supplier of the product, with pricing based on net sales. Hikma Pharmaceuticals PLC is a UK-based pharmaceutical company.

In July 2022, Grunenthal Group, a German pharmaceutical company, acquired the testosterone treatment Nebido from Bayer AG for approximately $547.4 million. This strategic move is part of Grunenthal's ongoing acquisition strategy, which includes global rights to Qutenza, rights to ex-Japanese company Zomig, global rights to ex-US company Vimovo, and European rights to Crestor and Nexium. Bayer AG, a German pharmaceutical company specializing in hormone therapy and treatments, was the seller in this acquisition.

Major companies operating in the hormone therapy market include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy's Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited

North America was the largest region in the hormone therapy market in 2024. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hormone therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormone therapy market includes revenues earned by entities by providing hormone therapies such as insulin therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormone Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormone therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormone therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormone therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy: Estrogen Hormone Replacement; Growth Hormone Replacement; Thyroid Hormone Replacement; Testosterone Replacement
• 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 3) By Indication: Menopause; Hypothyroidism; Growth Hormone Deficiency; Other Indications
• 4) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies And Stores; Online Pharmacies
• Subsegments:
• 1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy; Local Estrogen Therapy; Combination Estrogen-Progestin Therapy
• 2) By Growth Hormone Replacement: Recombinant Growth Hormones; Synthetic Growth Hormones
• 3) By Thyroid Hormone Replacement: Levothyroxine; Liothyronine; Natural Desiccated Thyroid
• 4) By Testosterone Replacement: Injectable Testosterone; Transdermal Testosterone; Oral Testosterone; Pellets
• Companies Mentioned: Abbott Laboratories; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormone Therapy Market Characteristics

3. Hormone Therapy Market Trends And Strategies

4. Hormone Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hormone Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hormone Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hormone Therapy Market Growth Rate Analysis
• 5.4. Global Hormone Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hormone Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hormone Therapy Total Addressable Market (TAM)

6. Hormone Therapy Market Segmentation

• 6.1. Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen Hormone Replacement
• Growth Hormone Replacement
• Thyroid Hormone Replacement
• Testosterone Replacement
• 6.2. Global Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes of Administration
• 6.3. Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Menopause
• Hypothyroidism
• Growth Hormone Deficiency
• Other Indications
• 6.4. Global Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacies
• Retail Pharmacies And Stores
• Online Pharmacies
• 6.5. Global Hormone Therapy Market, Sub-Segmentation Of Estrogen Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Estrogen Therapy
• Local Estrogen Therapy
• Combination Estrogen-Progestin Therapy
• 6.6. Global Hormone Therapy Market, Sub-Segmentation Of Growth Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Growth Hormones
• Synthetic Growth Hormones
• 6.7. Global Hormone Therapy Market, Sub-Segmentation Of Thyroid Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Levothyroxine
• Liothyronine
• Natural Desiccated Thyroid
• 6.8. Global Hormone Therapy Market, Sub-Segmentation Of Testosterone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Testosterone
• Transdermal Testosterone
• Oral Testosterone
• Pellets

7. Hormone Therapy Market Regional And Country Analysis

• 7.1. Global Hormone Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hormone Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormone Therapy Market

• 8.1. Asia-Pacific Hormone Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormone Therapy Market

• 9.1. China Hormone Therapy Market Overview
• 9.2. China Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormone Therapy Market

• 10.1. India Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormone Therapy Market

• 11.1. Japan Hormone Therapy Market Overview
• 11.2. Japan Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormone Therapy Market

• 12.1. Australia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormone Therapy Market

• 13.1. Indonesia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormone Therapy Market

• 14.1. South Korea Hormone Therapy Market Overview
• 14.2. South Korea Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormone Therapy Market

• 15.1. Western Europe Hormone Therapy Market Overview
• 15.2. Western Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormone Therapy Market

• 16.1. UK Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormone Therapy Market

• 17.1. Germany Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormone Therapy Market

• 18.1. France Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormone Therapy Market

• 19.1. Italy Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormone Therapy Market

• 20.1. Spain Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormone Therapy Market

• 21.1. Eastern Europe Hormone Therapy Market Overview
• 21.2. Eastern Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormone Therapy Market

• 22.1. Russia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormone Therapy Market

• 23.1. North America Hormone Therapy Market Overview
• 23.2. North America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormone Therapy Market

• 24.1. USA Hormone Therapy Market Overview
• 24.2. USA Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormone Therapy Market

• 25.1. Canada Hormone Therapy Market Overview
• 25.2. Canada Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormone Therapy Market

• 26.1. South America Hormone Therapy Market Overview
• 26.2. South America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormone Therapy Market

• 27.1. Brazil Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormone Therapy Market

• 28.1. Middle East Hormone Therapy Market Overview
• 28.2. Middle East Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormone Therapy Market

• 29.1. Africa Hormone Therapy Market Overview
• 29.2. Africa Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormone Therapy Market Competitive Landscape And Company Profiles

• 30.1. Hormone Therapy Market Competitive Landscape
• 30.2. Hormone Therapy Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Hormone Therapy Market Other Major And Innovative Companies

• 31.1. Mylan NV
• 31.2. Novartis AG
• 31.3. Novo Nordisk AS
• 31.4. Pfizer Inc.
• 31.5. Abbvie Inc.
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Perrigo Company Plc.
• 31.8. Cipla Inc.
• 31.9. Lupin Limited
• 31.10. Sun Pharmaceuticals Industries Ltd.
• 31.11. Hikma Pharmaceuticals PLC.
• 31.12. Johnsons & Johnsons Services Inc.
• 31.13. Boehringer Ingelheim International GmbH
• 31.14. Sanofi S.A.
• 31.15. AstraZeneca plc

32. Global Hormone Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormone Therapy Market

34. Recent Developments In The Hormone Therapy Market

35. Hormone Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Hormone Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hormone Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hormone Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer